Screening the CEACAM6 literature identified a strong association with various cancers, in particular colorectal cancer where measurement of CEACAM6 blood transcript levels may be of clinical value for early detection.14–16 Associations were also found for pancreatic, lung, and breast cancer, as well as leukemia and inflammatory bowel disease. Here, CEACAM6 is linked to leukemia.